EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential Impact of Biologic Use on Asthma‐Related Hospitalization: An Epidemiological Study in Hong Kong

Wang Chun Kwok iD, Chung Ki Tsui, Ting Fung Ma, Shuk Man Ngai, Lu Zhou, Isaac Sze Him Leung iD, Man Fung Tsoi iD, Raymond Yau Hang Leung, Ru Zhang, James Chung Man Ho iD

Canadian Respiratory Journal · 2026-01 · 2026 (1)

DOI: 10.1155/carj/5535762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Respiratory Journal, online erschienen am 15.07.2026. Verfasst von Wang Chun Kwok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong SAR, China, hku.hk. Hauptthemen laut MEDLINE: Asthma, Hospitalization, Biological Products. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the individual effects of biologics in asthma are well demonstrated, the potential impact of the use of biologics on overall asthma‐related hospitalization at a population‐based level has not been reported.

Methods

A territory‐wide study conducted in Hong Kong, involving all adult patients with asthma managed in Hospital Authority. The primary outcome was the change in asthma‐related hospitalization from 2014 to 2023, correlating with the number of biologic use among patients with asthma and adjusted for Air Quality Health Index and influenza case number.

Results

The weekly asthma‐related hospitalization was 96 episodes at the start of the study period and 78 episodes at the end of the study period. There was a significant reduction of asthma‐related hospitalization associated with biologic usage, giving the estimated risk ratio of 0.994 (95% CI = 0.991–0.996, p value < 0.05). The estimated break‐point for the change in asthma‐related hospitalization was at Week 169 (95% CI = 130.3–207.7), which was the week of 19/3/2017 to 25/3/2017. The slopes before and after the break‐point were 0.022 and −0.191 with the difference in the two slope estimates being significant ( p < 0.001) according to the Davies test. The significant difference in the slope before and after the break‐point suggested that beyond Week 169, there was a trend of significant reduction in asthma‐related hospitalization.

Conclusion

We observed a reduction in asthma‐related hospitalizations throughout the study period with a potential temporal association with the increase in biologic prescription. While biologics provided benefits in individual level, the possible benefits in a population‐based level could be related to a more comprehensive care in severe asthma patients from the introduction of biologics for severe asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHospitalizationBiological ProductsHumansHong KongFemaleMaleAdultMiddle AgedEpidemiologic StudiesAged

Stichwörter der Autor:innen

asthmaasthma exacerbationbiologics

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong SAR, China, hku.hk.
  • Department of Statistics, University of South Carolina, Columbia, South Carolina, USA, sc.edu.
  • Department of Statistics, The Chinese University of Hong Kong, Shatin, New Territories Hong Kong SAR, China, cuhk.edu.hk.

ORCID-Profile: Wang Chun Kwok, Isaac Sze Him Leung, Man Fung Tsoi, James Chung Man Ho

Förderung

  • GlaxoSmithKline

Zitieren

APA

Kwok, W. C., Tsui, C. K., Ma, T. F., Ngai, S. M., Zhou, L., Leung, I. S. H., Tsoi, M. F., Leung, R. Y. H., Zhang, R., & Ho, J. C. M. (2026). Potential Impact of Biologic Use on Asthma‐Related Hospitalization: An Epidemiological Study in Hong Kong. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/5535762

Vancouver

Kwok WC, Tsui CK, Ma TF, Ngai SM, Zhou L, Leung ISH, et al. Potential Impact of Biologic Use on Asthma‐Related Hospitalization: An Epidemiological Study in Hong Kong. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/5535762

BibTeX
@article{Kwok2026,
  author = {Kwok, Wang Chun and Tsui, Chung Ki and Ma, Ting Fung and Ngai, Shuk Man and Zhou, Lu and Leung, Isaac Sze Him and Tsoi, Man Fung and Leung, Raymond Yau Hang and Zhang, Ru and Ho, James Chung Man},
  title = {Potential Impact of Biologic Use on Asthma‐Related Hospitalization: An Epidemiological Study in Hong Kong},
  journal = {Canadian Respiratory Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carj/5535762}
}
Kostenlos starten →